SEARCH

SEARCH BY CITATION

References

  • 1
    Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80(Suppl. 1): 14771.
  • 2
    Marteau P, De Vrese M, Cellier C, Schrezenmeir J. Protection from gastrointestinal diseases using probiotics. Am J Clin Nutr 2001; 73(2 Suppl.): 430S6S.
  • 3
    Ballongue J. Bifidobacteria and probiotic action. In: Salminen S, von Wright A, eds. Lactic Acid Bacteria. New York: Marcel Decker, 1998: 519–87.
  • 4
    Marteau P, Pochart P, Bouhnik Y, et al. Survie dans l'intestin grêle de Lactobacillus acidophilus et Bifidobacterium sp. ingérés dans un lait fermenté: une base rationnelle pour l'utilisation des probiotiques chez l'homme. Gastroenterol Clin Biol 1992; 16: 258.
  • 5
    Bouhnik Y, Pochart P, Marteau P, et al. Fecal recovery in man of viable Bifidobacterium sp. ingested in a fermented milk. Gastroenterology 1992; 102: 8758.
  • 6
    Pochart P, Marteau P, Bouhnik Y, et al. Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am J Clin Nutr 1992; 55: 7880.
  • 7
    Berrada N, Lemeland JF, Laroche G, et al. Bifidobacterium from fermented milks: survival during gastric transit. J Dairy Sci 1991; 74: 40913.
  • 8
    Marteau P, Pochart P, Flourié B, et al. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in man. Am J Clin Nutr 1990; 52: 6858.
  • 9
    Duez H, Pelletier C, Cools S, et al. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces. J Appl Microbiol 2000; 88: 101927.DOI: 10.1046/j.1365-2672.2000.01073.x
  • 10
    Bouglé D, Roland N, Lebeurrier F, Arhan P. Effect of propionibacteria supplementation on fecal bifidobacteria and segmental colonic transit time in healthy human subjects. Scand J Gastroenterol 1999; 34: 1448.
  • 11
    Bouvier M, Méance S, Bouley C, Berta JL, Grimaud JC. Effects of consumption of a milk fermented with the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit times in healthy humans. Biosci Microflora: in press.
  • 12
    Tanaka H, Doesburg K, Iwasaki T, Mierau I. Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci 1999; 82: 25305.
  • 13
    Grill JP, Manginot-Dürr C, Schneider F, Ballongue J. Bifidobacteria and probiotic effects: action of Bifidobacterium species on conjugated bile salts. Curr Microbiol 1995; 31: 237.
  • 14
    Salvioli G, Salati R, Bondi M, et al. Bile acid transformation by the intestinal flora and cholesterol saturation in bile. Effect of Streptococcus faecium administration. Digestion 1982; 23: 808.
  • 15
    Chaussade S, Khyari A, Roche H, et al. Determination of total and segmental colonic transit time in constipated patients. Dig Dis Sci 1989; 34: 116872.
  • 16
    Stephen AM, Cummings JH. The microbial contribution to human faecal mass. J Med Microbiol 1980; 13: 4556.
  • 17
    Setchell KD, Lawson AM, Tanida N, Sjovall J. General methods for the analysis of metabolic profiles of bile acids and related compounds in feces. J Lipid Res 1983; 24: 1085100.
  • 18
    Isolauri E, Juntunen M, Rautanen T, et al. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991; 88: 907.
  • 19
    Shornikova AV, Casas IA, Mykkanen H, et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997; 16: 11037.DOI: 10.1097/00006454-199712000-00002
  • 20
    Saavedra JM, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344: 10469.
  • 21
    Goldin BR, Gorbach SH. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984; 39: 75661.
  • 22
    Biasco G, Paganelli GM, Owen RW, et al. Faecal bile acids and colorectal cell proliferation. The ECP Colon Cancer Working Group. Eur J Cancer Prev 1991; 1(Suppl. 2): 638.
  • 23
    Latta RK, Fiander H, Ross NW, et al. Toxicity of bile acids to colon cancer cell lines. Cancer Lett 1993; 70: 1677.
  • 24
    Paumgartner A, Ochsenkuhn T, Bayerdorffer E, et al. Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer 1999; 85: 16649.
  • 25
    Lewis SJ, Heaton KW. The metabolic consequences of slow colonic transit. Am J Gastroenterol 1999; 94: 20106.
    Direct Link:
  • 26
    Schneider H, Schwiertz A, Collins MD, Blaut M. Anaerobic transformation of quercetin-3-glucoside by bacteria from the human intestinal tract. Arch Microbiol 1999; 17: 8191.
  • 27
    Cargill G, Salin B, Lubin S, et al. Effect of phloroglucinol on rectosigmoid motility stimulated by a test meal. Study in patients with irritable bowel syndrome. Presse Med 1992; 21: 1923(in French).